by Olmo F, Hesketh A, Hage H, Monneuse J-M, Taylor MC, Costa FC, Da Silva C, Bequet F, Escudié F, Mercer D, Saliou A, Chatelain E, Kelly JM, Abi-Ghanem J. Communications Biology 2026. doi:10.1038/s42003-026-11251-3
Summary: Eliminating a non-replicating Trypanosoma cruzi sub-population that can persist after treatment for Chagas disease is a key challenge in drug discovery. The authors of this manuscript describe the transcriptome and proteome profiles of a low-proliferative sub-population of epimastigote forms of the parasite isolated from exponentially growing cultures. This partially quiescent sub-population was characterised by down-regulation of genes/proteins involved in translation, transcription, metabolism, mitochondrial function, and DNA replication, and by up-regulation of proteins that promote exit from the cell cycle in other organisms. Differential expression was considerably more pronounced at a protein than an RNA level. These data provide a resource that can be exploited to dissect the mechanistic basis of quiescence, as a step towards refining the drug-development screening cascade.